We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

FOR PREVIEW ONLY (Print)

Jennelle Hodge, PhD, FACMG

Associate Director, Cytogenetics Laboratory

Associate Professor, Pathology and Lab Medicine

Associate Professor, Biomedical Sciences

Scientific Director, Molecular Pathology Laboratory

Jennelle Hodge, PhD, FACMG

Associate Director, Cytogenetics Laboratory

Associate Professor, Pathology and Lab Medicine

Associate Professor, Biomedical Sciences

Scientific Director, Molecular Pathology Laboratory

The research interests of Jennelle Hodge, FACMG, PhD, includes development and implementation of innovative technologies for molecular and cytogenomic clinical diagnostics; mining of genomic data for genotype and phenotype correlation; and genetics of solid tumors, particularly prostate cancer and uterine neoplasms.

  • Undergraduate: Rochester Institute of Technology, 1999
  • Doctorate: Medical College of Wisconsin, 2003
  • Fellowship: Harvard Medical School, 2005
  • Fellowship: Harvard Medical School, 2006
  • Post Doctorate: Brigham and Women's Hospital, 2007

View CV as a PDF

  • Annual Meeting Program Committee, American College of Medical Genetics, 2015-17
  • Moderator: ACMG platform session, 2014
  • Moderator: ASHG platform session, 2012
  • Fellow of the American College of Medical Genetics status granted, 2010
  • Reviewer: American Journal of Medical Genetics
  • Reviewer: American Journal of Obstetrics and Gynecology
  • Reviewer: Cancer Genetics and Cytogenetics
  • Reviewer: European Journal of Human Genetics
  • Reviewer: Molecular Human Reproduction
  • Reviewer: PLos One
  • Member, American Society of Human Genetics
  • Member, Association of Molecular Pathologists

Show moreShow less

  • Hand J, Runke C, Hodge JC. The phenotype spectrum of X-linked ichthyosis identified by chromosomal microarray. J Am Acad Dermatol. 2015;72(4):617-627.
  • Hodge JC, Pearce KE, Clayton AC, Taran FA, Stewart EA. Uterine cellular leiomyomata with chromosome 1p deletions represent a distinct entity. Am J Obstet Gynecol. 2014;210(6):572.e1-7.
  • Hodge JC, Mitchell E, Pillalamarri V, Toler TL, Bartel F, Kearney HM, Zou YS, Tan W-H, Hanscom C, Kirmani S, et al. Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities. Mol Psych. 2014;19(3):368-379.
  • Hodge JC, Pearce KE, Wang X, Wiktor AE, Oliveira AM, Greipp PT. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases. Mod Pathol. 2013;27(1):113-127.
  • Hodge JC, Kim TM, Dreyfuss JM, Somasundaram P, Christacos NC, Rousselle M, Quade BJ, Park PJ, Stewart EA, Morton CC. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profiling of the t(12;14) and evidence in support of predisposing genetic heterogeneity. Hum Mol Genet. 2012;21(10):2312-2329.
  • Hodge JC, T. Cuenco K, Huyck KL, Somasundaram P, Panhuysen CIM, Stewart EA, Morton CC. Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele. Hum Genet. 2009;125:257-263.

Show moreShow less

Send Email to Jennelle Hodge, PhD, FACMG